Hims & Hers (HIMS) CLO Soleil Boughton Sells 6,236 Shares

What Happened
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 6,236 shares on September 16, 2026 at $27.86 per share, for proceeds of roughly $173,735. This was a sale (not a purchase or option exercise) and is typically viewed as routine insider selling rather than a fresh vote of confidence.

Key Details

• Transaction date: 2026-09-16; reported on Form 4 filed 2026-09-17.
• Price and amount: 6,236 shares sold at $27.86 each; total ≈ $173,735.
• Transaction type: Sale (code S); described as "open market or private sale" on the filing.
• Footnote: Sale was made pursuant to a Rule 10b5-1 trading plan adopted by Boughton on May 21, 2026.
• Shares owned after transaction: Not specified in the provided filing summary.
• Timeliness: Filing covers a 2026-09-16 transaction and was filed the next day (2026-09-17); no late filing indicated in the data provided.

Context
A 10b5-1 plan lets insiders pre-schedule trades to avoid trading on material nonpublic information; sales under such plans are often routine and do not necessarily reflect the insider’s current view of the company. For retail investors, purchases generally carry more weight as a signal than routine, pre-arranged sales.